Oct 2026
Dual-Targeting of ER Stress and the CD47-SIRPα Axis via an In Situ Hydrogel Prevents Postoperative Glioblastoma Recurrence.
An injectable, photo-crosslinkable carboxymethyl chitosan (CMCS)-based hydrogel was engineered to achieve localized, synergistic chemo-immunotherapy within the surgical cavity, offering a potent solution to combat malignant glioma recurrence.
Xue Guan, Wei Zhang, Yu-Jie Wang et al.
· Small · 0 citations